| Literature DB >> 31941962 |
Tomásia Fernandes1, Antera Martel2, Nereida Cordeiro3,4.
Abstract
To uncover the potential of Pavlova pinguis J.C. Green as a natural source of value added compounds, its lipophilic extracts were studied before and after alkaline hydrolysis using gas chromatography-mass spectrometry (GC-MS). The GC-MS analysis of the lipophilic extracts showed a wide chemical diversity including 72 compounds distributed by fatty acids (29), sterols (14), fatty alcohols (13) and other lipophilic compounds (16). Fatty acids represented the main class of identified compounds presenting myristic, palmitic, palmitoleic and eicosapentaenoic acids as its main components. Through the ∑ω6/∑ω3 ratio (0.25) and sterol composition it was possible to observe that P. pinguis is a valuable source of ω3 fatty acids and stigmasterol (up to 43% of total sterols). After alkaline hydrolysis, fatty acids and fatty alcohols content increased by 32 and 14% respectively, in contrast to, monoglycerides which decreased by 84%. The long chain alcohols content enables the exploitation of this microalga as a source of these bioactive compounds. Smaller amounts of sugars and other compounds were also detected. The present study is a valuable reference to the metabolite characterization of P. pinguis and shows the potential of this microalga for nutraceutical and pharmaceutical industries.Entities:
Year: 2020 PMID: 31941962 PMCID: PMC6962392 DOI: 10.1038/s41598-019-57188-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Growth curve of P. pinguis in f/2 growth medium.
Figure 2FTIR–ATR spectra of the lipophilic extractives and the raw marine microalga P. pinguis, the characteristic bands of the lipophilic extracts are highlighted.
Compounds detected in the lipophilic extracts of P. pinguis before (BH) and after (AH) alkaline hydrolysis.
| N° | Identified Compounds | MW | Content (mg g−1 of microalgal dw) | Content (mg g−1 of extract) | ||
|---|---|---|---|---|---|---|
| BH | AH | BH | AH | |||
| 2 | Octanoic acid | 216 | 1.03 ± 0.00 | 8.65 ± 0.27 | ||
| 4 | Nonanoic acid | 230 | 0.77 ± 0.00a | 1.05 ± 0.01b | 6.49 ± 0.23a | 8.78 ± 0.20b |
| 6 | Decanoic acid | 244 | 1.03 ± 0.01 | 8.62 ± 0.34 | ||
| 13 | Dodecanoic acid | 272 | 0.78 ± 0.01a | 1.05 ± 0.01b | 6.54 ± 0.28a | 8.79 ± 0.27b |
| 17 | Myristic acid | 300 | 7.43 ± 0.41a | 9.43 ± 0.54b | 62.62 ± 5.37a | 78.86 ± 4.03b |
| 20 | Pentadecanoic acid | 314 | 1.06 ± 0.02a | 1.38 ± 0.03b | 8.91 ± 0.45a | 11.53 ± 0.25b |
| 28 | Palmitic acid (PA) | 328 | 7.32 ± 0.22a | 9.97 ± 1.66b | 61.71 ± 3.62a | 83.13 ± 11.56b |
| 18 | Hexadecanoic methyl ester | 270 | 0.85 ± 0.01a | 1.05 ± 0.01b | 7.14 ± 0.34a | 8.79 ± 0.36b |
| 30 | Heptadecanoic acida | 342 | 2.54 ± 0.01a | 3.26 ± 0.02b | 21.37 ± 0.58a | 27.29 ± 0.71b |
| 39 | 2-Octyl-Cyclopropaneheptanoic acid | 354 | 0.82 ± 0.00a | 1.09 ± 0.01b | 6.89 ± 0.23a | 9.10 ± 0.31b |
| 38 | Octadecanoic acid | 356 | 1.81 ± 0.03a | 3.07 ± 0.50b | 15.24 ± 0.67a | 25.61 ± 3.40b |
| 46 | Eicosanoic acid | 384 | 0.79 ± 0.00a | 1.07 ± 0.01b | 6.69 ± 0.24a | 8.93 ± 0.20b |
| 53 | Docosanoic acid | 412 | 0.83 ± 0.02a | 1.07 ± 0.01b | 7.00 ± 0.24a | 8.94 ± 0.23b |
| 24 | Palmitoleic acida | 326 | 10.97 ± 0.39a | 13.06 ± 0.78b | 92.46 ± 6.15a | 109.19 ± 5.00b |
| 25 | 7-Hexadecenoic acid | 326 | 0.92 ± 0.02a | 1.17 ± 0.01b | 7.75 ± 0.37a | 9.79 ± 0.31b |
| 37 | Vaccenic acid | 354 | 1.27 ± 0.08a | 1.72 ± 0.16b | 10.68 ± 0.98a | 14.33 ± 0.91b |
| 36 | Oleic acid | 354 | 1.25 ± 0.08a | 1.89 ± 0.08b | 10.55 ± 0.93a | 15.76 ± 0.28b |
| 44 | Gondoic acid | 382 | 0.79 ± 0.00 | 6.68 ± 0.22a | ||
| 22 | 4,7,10,13-Hexadecatetraenoic acid | 322 | 0.82 ± 0.01a | 1.08 ± 0.01b | 6.91 ± 0.27a | 9.01 ± 0.29b |
| 26 | Methyl-4,7,10,13-hexadecatetraenoate | 262 | 0.85 ± 0.01a | 1.05 ± 0.00b | 6.86 ± 0.27a | 8.80 ± 0.28b |
| 34 | Linoleic acid (LA)a | 352 | 1.86 ± 0.03a | 2.58 ± 0.03b | 15.65 ± 0.71a | 21.59 ± 0.81b |
| 35 | α-Linolenic acid (ALA) | 350 | 0.89 ± 0.01a | 1.18 ± 0.02b | 7.49 ± 0.30a | 9.90 ± 0.29b |
| 33 | Stearidonic acid (SA) | 348 | 2.82 ± 0.09a | 3.04 ± 0.41a | 23.80 ± 1.47a | 25.39 ± 2.67a |
| 32 | 3,6,9,12,15-Octadecapentaenoic acid | 346 | 0.90 ± 0.01a | 1.18 ± 0.02b | 7.60 ± 0.30a | 9.84 ± 0.33b |
| 42 | Eicosapentaenoic acid (EPA) | 374 | 3.49 ± 0.09a | 4.73 ± 0.26b | 29.43 ± 1.44a | 39.54 ± 1.51b |
| 48 | 7,10,13,16,19-Docosapentaenoic acid | 402 | 1.59 ± 0.08a | 2.05 ± 0.08b | 13.36 ± 0.68a | 17.14 ± 0.51b |
| 49 | 4,7,10,13,16-Docosapentaenoic acid | 402 | 1.11 ± 0.02a | 1.53 ± 0.06b | 9.37 ± 0.32a | 12.80 ± 0.32b |
| 47 | Docosahexaenoic acid (DHA) | 400 | 2.01 ± 0.10a | 2.67 ± 0.15b | 16.91 ± 0.76a | 22.30 ± 0.95b |
| 50 | Octadecenedioic acid | 456 | 0.81 ± 0.01a | 1.12 ± 0.03b | 6.86 ± 0.27a | 9.37 ± 0.33b |
| 1 | 1-Octanol | 202 | 1.20 ± 0.08 | 10.05 ± 0.35 | ||
| 7 | 1-Undecanol | 244 | 0.63 ± 0.01a | 0.83 ± 0.00b | 5.31 ± 0.24a | 6.93 ± 0.23b |
| 12 | 1-Dodecanol | 258 | 0.63 ± 0.00a | 0.83 ± 0.01b | 5.28 ± 0.18a | 6.99 ± 0.25b |
| 14 | 1-Tridecanol | 272 | 0.64 ± 0.01a | 0.83 ± 0.01b | 5.36 ± 0.26a | 6.98 ± 0.25b |
| 16 | 1-Tetradecanol | 286 | 0.67 ± 0.01a | 0.88 ± 0.01b | 5.61 ± 0.26a | 7.36 ± 0.17b |
| 21 | 1-Hexadecanol | 314 | 1.50 ± 0.09a | 1.21 ± 0.08b | 12.63 ± 0.39a | 10.07 ± 0.42b |
| 31 | 1-Octadecanol | 342 | 1.18 ± 0.06a | 1.17 ± 0.07a | 9.94 ± 0.16a | 9.81 ± 0.31a |
| 29 | Octadece-9-nol | 340 | 1.46 ± 0.12a | 1.21 ± 0.12b | 12.29 ± 0.62a | 10.10 ± 0.72b |
| 43 | 1-Eicosanol | 368 | 0.69 ± 0.01 | 5.77 ± 0.15a | ||
| 51 | 1-Docosanol | 396 | 0.65 ± 0.01a | 0.85 ± 0.00b | 5.48 ± 0.13a | 7.10 ± 0.19b |
| 58 | 1-Octacosanol | 482 | 0.97 ± 0.02a | 1.02 ± 0.06a | 8.13 ± 0.18a | 8.54 ± 0.25b |
| 71 | 1-Dotriacontanol | 538 | 0.68 ± 0.00a | 0.86 ± 0.01b | 5.73 ± 0.15a | 7.21 ± 0.21b |
| 57 | 22-Stigmasten-3-one | 412 | 0.26 ± 0.02 | 2.15 ± 0.20a | ||
| 59 | Stigmastane-3,6-dione | 428 | 0.34 ± 0.06a | 0.19 ± 0.01b | 2.84 ± 0.58a | 1.56 ± 0.09b |
| 60 | Campesterol | 472 | 0.57 ± 0.02a | 0.56 ± 0.03a | 4.81 ± 0.29a | 4.71 ± 0.26a |
| 61 | Stigmasterol | 484 | 6.14 ± 0.52a | 5.07 ± 0.29b | 51.75 ± 5.69a | 42.38 ± 1.99b |
| 62 | 24-Ethyl-δ(22)-coprostenol | 486 | 0.75 ± 0.10a | 0.63 ± 0.04a | 6.31 ± 0.92a | 5.25 ± 0.31a |
| 63 | β-Sitosterol | 486 | 0.78 ± 0.03a | 0.90 ± 0.21a | 6.53 ± 0.31a | 7.46 ± 1.55a |
| 64 | 4α,24-Dimethyl-5α-cholestan-3β-ol | 488 | 1.09 ± 0.04a | 0.95 ± 0.11a | 9.22 ± 0.57a | 7.97 ± 0.72b |
| 66 | 4α-methyl,24-ethyl-5α-cholest-22E-en-3β-ol | 500 | 0.77 ± 0.04a | 0.70 ± 0.10b | 6.52 ± 0.54a | 5.82 ± 0.71a |
| 68 | 4α-methyl-24-ethyl-5α-cholestan-3-ol | 502 | 0.34 ± 0.03 | 2.86 ± 0.23 | ||
| 69 | 4α,24β-dimethyl-5α-cholestan-3β,4β-diol | 504* | 0.37 ± 0.04a | 0.32 ± 0.02a | 3.10 ± 0.44a | 2.65 ± 0.2a |
| 72 | 4α-methyl-24β-ethyl-5α-cholestan-3β,4β-diol | 518* | 0.71 ± 0.09a | 0.58 ± 0.05b | 6.04 ± 0.93a | 4.88 ± 0.32a |
| 67 | Unidentified C30 Sterol | 1.96 ± 0.12a | 1.64 ± 0.18b | 16.48 ± 1.35a | 13.66 ± 1.12b | |
| 70 | Unidentified C30 Sterol | 0.17 ± 0.01a | 0.21 ± 0.01b | 1.45 ± 0.08a | 1.76 ± 0.12b | |
| 65 | Unidentified C30 Sterol | 0.36 ± 0.02a | 0.71 ± 0.07b | 3.06 ± 0.26a | 5.90 ± 0.46b | |
| 40 | 1-Monotridecanoin | 432 | 0.06 ± 0.00a | 0.04 ± 0.01b | 0.52 ± 0.05a | 0.37 ± 0.05b |
| 45 | Monomyristin | 446 | 0.09 ± 0.01 | 0.72 ± 0.05a | ||
| 52 | Monopalmitin | 474 | 0.07 ± 0.01 | 0.59 ± 0.07a | ||
| 55 | Monostearin | 502 | 0.06 ± 0.01 | 0.48 ± 0.07a | ||
| 19 | Rhamnose | 452 | 0.21 ± 0.01 | 1.85 ± 0.02 | ||
| 27 | Deoxyglucose | 452 | 0.20 ± 0.01 | 1.79 ± 0.00 | ||
| 56 | Glucosamine | 612 | 0.17 ± 0.01 | 1.42 ± 0.10a | ||
| 3 | 2,4,6,8-Tetramethyl-1-undecene | 210 | 0.03 ± 0.00 | 0.21 ± 0.04a | ||
| 5 | 2-Methyltetradecane | 212 | 0.05 ± 0.01 | 0.46 ± 0.07a | ||
| 8 | 2-Methyl-4-nonadecene | 280 | 0.03 ± 0.00 | 0.24 ± 0.04a | ||
| 10 | 3-Methyl-4-nonadecene | 280 | 0.04 ± 0.01a | 0.05 ± 0.01a | 0.32 ± 0.07a | 0.41 ± 0.10a |
| 9 | 2,6-bis(1,1-Dimethylethyl)phenol | 278 | 0.99 ± 0.02a | 1.56 ± 0.08b | 8.43 ± 0.43a | 13.02 ± 0.28b |
| 15 | Methylsuccinic acid | 276 | 0.05 ± 0.01 | 0.45 ± 0.04a | ||
| 11 | 3-Methoxycinnamic acid | 250 | 1.18 ± 0.01 | 9.88 ± 0.38 | ||
| 41 | Dehydroabietic acid | 372 | 0.18 ± 0.02a | 0.66 ± 0.05b | 1.49 ± 0.13a | 5.55 ± 0.49b |
| 54 | Pinoresinol | 502 | 1.30 ± 0.03 | 10.85 ± 0.55 | ||
| 23 | Mannitol | 614 | 0.65 ± 0.00a | 0.85 ± 0.01b | 5.46 ± 0.21a | 7.13 ± 0.29b |
Values (means ± SD of four replicates) in the same row, not sharing a common superscript are significantly different (p < 0.05). Compounds are numbered by their elution order (see Fig. 2). All the compounds containing hydroxyl and/or carboxyl groups are identified as the correspondent TMS derivatives. MW – Molecular weight of compounds after silylation. aContains the iso- and anteiso-isomers; bContains cis and trans isomers; *Identified as the mono-TMS ether; n.d. – non detected; dw – dry weight.
Figure 3Chromatogram of the derivatized P. pinguis lipophilic extract after alkaline hydrolysis. Peak identification as in Table 1. IS – Internal Standard (Tetracosane, 0.40 mg).
Figure 4Main families identified in P. pinguis lipophilic extracts (a) before and (b) after alkaline hydrolysis, in percentage of the total identified compounds.
Figure 5Mass spectra of some assigned peaks as trimethylsilyl (TMS) ethers and/or esters: (a) Octadece-9-nol (peak 29), (b) Monomyristin (peak 45), (c) Pinoresinol (peak 54) and (d) 4α-methyl-24β-ethyl-5α-cholestan-3β,4β-diol as mono TMS ether (peak 72).
Figure 62,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity (%) of P. pinguis chloroform extracts (µg mL−1). Butylated hydroxytoluene (BHT) was used as a reference compound and its EC50 value is 9.79 𝜇g mL−1.